Eisai (OTC: ESALY)
Some price data may be temporarily unavailable.
Eisai Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Eisai Company Info
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.
News & Analysis
Why Arena Pharmaceuticals Stock Is Surging Higher Today
The biopharma's shares soared by double-digits Wednesday on a strong Q4 earnings release.
Why Arena Pharmaceuticals Stock Sank in 2016
Belviq's weak sales weighed heavily on Arena's stock last year.
How Marijuana Could Play a Role in Alzheimer's Disease Treatment
Experts think they know how to treat Alzheimer's disease, but it won't be easy. Here's how cannabis could help.
Corcept Therapeutics Rose 18% in March. Here's Why.
An earnings report chock full of good news causes shares to move in the right direction.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.